Back to search
FDAFDA · Food and drugs·Recall number D-0881-2022

Sirolimus Oral Solution, 1 mg/mL, 60 mL bottle, Rx Only, Manufactured by: Apotex Inc. Toronto, Ontario Canada M9L 1T9 Manufactured for: Apotex Corp. Weston, Florida 33326, NDC 60505-6197-2

Published May 25, 2022 · Recall initiated: May 3, 2022

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specifications: Sirolimus Oral Solution recalled due to lot RZ1598 exceeded the specification limit at the 14-month timepoint.

What to do

Voluntary: Firm initiated · Letter

Recall details

Brand
SIROLIMUS
Manufacturer
Apotex Corp.
Distributor
Nationwide in the USA
Lot
Lot: RZ1598, exp. date 02/2023
Risk classification
Class III
Area (FDA)
drug
Country
United States

Sell products like this?

Recalert watches your whole catalog for recalls like this one, automatically.

Start free — no card